Mechanisms for Individual Differences in Hypertension in Obstructive Sleep
NCT03176732 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 155
Last updated 2023-04-26
Summary
Hypertension is a common consequence of obstructive sleep apnea (OSA). However, not all individuals with OSA have hypertension and there are major individual differences in blood pressure response to positive airway pressure treatment of OSA. This project is focused on determining the basis of these individual differences in blood pressure response to OSA and will evaluate the possible underlying reasons for these differences. The results will help clinicians to know whether or not to expect a reduction in blood pressure (BP) to OSA treatment in a given patient and thereby personalize patient management.
Conditions
- Sleep Apnea, Obstructive
- Hypertension
Interventions
- DEVICE
-
Positive Airway Pressure
Participants will use Positive Airway Pressure (PAP) treatment
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH - lead OTHER
Principal Investigators
-
Samuel T Kuna, MD · University of Pennsylvania
-
Raymond R Townsend, MD · University of Pennsylvania
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-06-06
- Primary Completion
- 2022-04-30
- Completion
- 2022-06-30
Countries
- United States
- Iceland
Study Locations
More Related Trials
-
Effect of CPAP on Blood Pressure in Patients With Sleep Apnea and Refractory Hypertension
NCT00863135 ·Status: COMPLETED ·Phase: NA
-
Effect of Continuous Positive Airway Pressure (CPAP) on Hypertension and Cardiovascular Morbidity-Mortality in Patients With Sleep Apnea and no Daytime Sleepiness
NCT00127348 ·Status: COMPLETED ·Phase: PHASE4
-
Antihypertensive Effect of Continuous Positive Airway Pressure in Resistant Hypertensive Patients With Sleep Apnea
NCT00929175 ·Status: COMPLETED ·Phase: PHASE4
-
Masked Hypertensive Patients With Obstructive Sleep Apnea
NCT04251975 ·Status: COMPLETED ·Phase: NA
-
Efficacy of CPAP Treatment on Blood Pressure of Resistant Hypertension Patients With Obstructive Sleep Apnea Syndrome
NCT01508754 ·Status: COMPLETED ·Phase: PHASE4
-
Sleep Apnea and Refractory Hypertension: Prevalence and Effect of CPAP Treatment
NCT00459914 ·Status: COMPLETED ·Phase: PHASE2
-
Continuous Monitoring Nocturnal Beat-to-beat Blood Pressure Fluctuation in OSA With or Without Hypertension
NCT02876471 ·Status: COMPLETED ·Phase: NA
-
Long-term Cardiovascular Outcomes in Patients With RH and OSA With or Without Treatment With CPAP
NCT03002558 ·Status: COMPLETED
-
Effect of Continuous Positive Airway Pressure (CPAP) Treatment in the Control of Refractory Hypertension
NCT00616265 ·Status: COMPLETED ·Phase: NA
-
MicroRNAs as Biomarkers for Obstructive Sleep Apnea
NCT06189755 ·Status: RECRUITING
-
Biomarkers for Obstructive Sleep Apnea
NCT00834509 ·Status: COMPLETED
-
Effects of Continuous Positive Airway Pressure (CPAP) in Patients With Resistant Hypertension and Obstructive Sleep Apnea (OSA)
NCT00812695 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Obstructive Sleep Apnea and Its Intervention on Coronary Heart Disease
NCT02059993 ·Status: COMPLETED ·Phase: NA
-
Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep Apnea
NCT04575740 ·Status: COMPLETED ·Phase: NA
-
Vasoactive Hormones During the Night in Patients With Obstructive Sleep Apnea Before and After Treatment With CPAP.
NCT00360659 ·Status: COMPLETED ·Phase: PHASE4
-
Novel physIologiC prEdictors of Positive Airway Pressure Effectiveness
NCT05067088 ·Status: ACTIVE_NOT_RECRUITING
-
Normotensive OSA Patients With Nondipper Circadian Blood Pressure Pattern
NCT03987425 ·Status: COMPLETED ·Phase: NA
-
Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary Hypertension
NCT05595200 ·Status: RECRUITING
-
"Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"
NCT01317329 ·Status: COMPLETED ·Phase: NA
-
Characteristics of Obstructive Sleep Apnea Syndrome Related Hypertension and the Effect of Continuous Positive Airway Pressure Treatment on Blood Pressure
NCT03246022 ·Status: COMPLETED
-
Cardiovascular Impact of Obstructive Sleep Apnea Treatment in Normotensive Patients
NCT00741520 ·Status: COMPLETED ·Phase: PHASE4
-
Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease
NCT00738179 ·Status: UNKNOWN ·Phase: PHASE3
-
Obstructive Sleep Apnea in the Absence of Metabolic Syndrome
NCT01635010 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Continuous Positive Airway Pressure (CPAP) on Systemic Blood Pressure, Coagulability and Carotid Intima-media Thickness in Patients With Sleep Apnea
NCT00300599 ·Status: COMPLETED ·Phase: NA
-
Obstructive Sleep Apnea (OSA) in Pulmonary Arterial Hypertension (PAH)
NCT01835080 ·Status: TERMINATED